Global RNA Based Therapeutics Market By RNA Modality (Small interfering RNA (siRNA), Micro RNA (miRNA), Antisense Oligonucleotide (ASO), Others); By Route of Administration (Intravenous, Subcutaneous, Others); By Therapeutic Indication (Oncology, Cardiovascular Disease, Genetic Diseases, Infectious Diseases, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia(Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia) Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029